Latest News
Eli Lilly has taken a commanding position in the obesity drug market with its GLP-1 agonist Zepbound, and now the pharma giant is preparing for ...
Tesla is confronting a barrage of challenges that have rattled its dominance in the EV market and clouded the outlook for its ambitious robotaxi rollout. ...
US stock markets once again had a mixed performance on Friday, with the Dow Jones Industrial Average dipping. ...
Stocks in the crypto sector were significantly boosted following President Trump’s recent endorsement of the GENIUS Act, which aims to regulate stablecoins in the U.S. ...







